Information  X 
Enter a valid email address

Protherics PLC (PTI)

  Print      Mail a friend       Annual reports

Friday 13 June, 2008

Protherics PLC

Holding(s) in Company

RNS Number : 7323W
Protherics PLC
13 June 2008
 



Protherics PLC


Notification of Major Interests in Shares



London, UK; Brentwood, TN, US: 13 June 2008 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces that today, in accordance with the Transparency Obligations Directive, notification of interest in the ordinary share capital of the Company was received from Invesco Perpetual on behalf of Perpetual Income and Growth Investment Trust. Details of the interest notified are as follows:



1.    Reason for the notification (please tick the appropriate box or boxes)    




An disposal of voting rights 


Yes

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached



An event changing the breakdown of voting rights



Other (please specify):


2. Full name of person(s) subject to the notification obligation:

Perpetual Income and Growth Investment Trust

3. Full name of shareholder(s) (if different from 2.):



4. Date of the transaction (and date on which the threshold is crossed or reached if different):

12 June 2008

5. Date on which issuer notified:

13 June 2008

6. Threshold(s) that is/are crossed or reached:

crossed 4% threshold into 3%

7. Notified details:


A: Voting rights attached to shares

Class/type of shares 

if possible using the ISIN CODE

Situation previous to the Triggering transaction 

Resulting situation after the triggering transaction

Number of Shares 

Number of Voting Rights 

Number of shares 

Number of voting rights 

% of voting rights

Direct

Indirect 

Direct

Indirect

 

Ordinary 2P Shares

(GB0007029209)



14,348,079


14,348,079


13,568,085




13,568,085




3.98%


B: Financial Instruments

Resulting situation after the triggering transaction 

Type of financial instrument 

Expiration date 

Exercise/ Conversion Period/ Date 

Number of voting rights that may be acquired if the instrument is exercised/ converted. 

% of voting rights












Total (A+B)

Number of voting rights

% of voting rights


13,568,085


3.98%


8. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable :

Name of Company/Fund


Number of Shares

% of issued share capital


Citibank



13,568,085



3.98%   



Proxy Voting:

9.   Name of the proxy holder:


10. Number of voting rights proxy holder will
      cease to hold:


11. Date on which proxy holder will cease to
      hold voting    rights:



12. Additional information:





| Ends |


For further information please contact:


Protherics 


Nick StaplesDirector of Corporate Affairs

+44 (0) 7919 480510  

Julie Vickers, Company Secretary 

+44 (0)1928 518010



Financial Dynamics - press enquiries


London: Ben Atwell, Lara Mott

+44 (0) 20 7831 3113 

New York: John Capodanno, Jonathan Birt

+1 212 850 5600


Or visit  www.protherics.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLQXLFFVQBZBBX

a d v e r t i s e m e n t